Horizon Internal Medicine is categorized under Internal Medicine Doctors in Las Vegas, NV and active since 2007.
Horizon Internal Medicine was established in 2007, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Petar Jamborcic at the company’s single location by writing to 604 Highland Bluff Way, Las Vegas, Nevada NV 89138 or by phoning (702) 876-1483. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Horizon Internal Medicine |
| Contact Person: | Petar Jamborcic |
| Address: | 604 Highland Bluff Way, Las Vegas, Nevada 89138 |
| Phone Number: | (702) 876-1483 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Horizon Internal Medicine was started in 2007 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Petar Jamborcic for inquiries that concern Horizon Internal Medicine by calling the company number (702) 876-1483, as your correspondence is most welcome. Additionally, the physical location of the single location of Horizon Internal Medicine can be found at the coordinates 36.1549,-115.2003 as well as the street address 604 Highland Bluff Way in Las Vegas, Nevada 89138.
For its online presence, you may visit Horizon Internal Medicine’s website at and engage with its social media outlets through on Twitter and on Facebook.